Gitte‐Bettina Nyvang

430 total citations
10 papers, 303 citations indexed

About

Gitte‐Bettina Nyvang is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Gitte‐Bettina Nyvang has authored 10 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Reproductive Medicine and 3 papers in Molecular Biology. Recurrent topics in Gitte‐Bettina Nyvang's work include Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (5 papers) and Cervical Cancer and HPV Research (2 papers). Gitte‐Bettina Nyvang is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (5 papers) and Cervical Cancer and HPV Research (2 papers). Gitte‐Bettina Nyvang collaborates with scholars based in Denmark, Italy and France. Gitte‐Bettina Nyvang's co-authors include Jacob Christian Lindegaard, Erik Morre Pedersen, S.K. Nielsen, Lars Fokdal, Lisbeth Røhl, Kari Tanderup, Ole Mogensen, Jørn Herrstedt, Doris Schledermann and Anja Ør Knudsen and has published in prestigious journals such as Journal of Clinical Oncology, Radiotherapy and Oncology and Gynecologic Oncology.

In The Last Decade

Gitte‐Bettina Nyvang

10 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gitte‐Bettina Nyvang Denmark 7 164 115 94 93 57 10 303
Frédéric Kridelka Belgium 10 195 1.2× 94 0.8× 98 1.0× 37 0.4× 10 0.2× 34 324
Jacob P. Hoogendam Netherlands 11 133 0.8× 67 0.6× 110 1.2× 48 0.5× 8 0.1× 32 279
Wharton Jt United States 7 176 1.1× 100 0.9× 91 1.0× 67 0.7× 14 0.2× 13 310
Bastiaan G. Wortman Netherlands 4 280 1.7× 41 0.4× 223 2.4× 23 0.2× 9 0.2× 5 334
Emily MacDuffie United States 9 45 0.3× 44 0.4× 53 0.6× 122 1.3× 8 0.1× 27 269
L Ševčík Czechia 8 314 1.9× 84 0.7× 145 1.5× 75 0.8× 5 0.1× 16 372
M. Tiffany United Kingdom 4 315 1.9× 168 1.5× 108 1.1× 125 1.3× 7 0.1× 4 575
R. Houghton Australia 7 209 1.3× 115 1.0× 76 0.8× 49 0.5× 4 0.1× 10 293
James L. Wilder United States 6 231 1.4× 54 0.5× 205 2.2× 38 0.4× 4 0.1× 6 312
Caroline Lundgren Sweden 9 593 3.6× 65 0.6× 501 5.3× 55 0.6× 9 0.2× 18 696

Countries citing papers authored by Gitte‐Bettina Nyvang

Since Specialization
Citations

This map shows the geographic impact of Gitte‐Bettina Nyvang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gitte‐Bettina Nyvang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gitte‐Bettina Nyvang more than expected).

Fields of papers citing papers by Gitte‐Bettina Nyvang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gitte‐Bettina Nyvang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gitte‐Bettina Nyvang. The network helps show where Gitte‐Bettina Nyvang may publish in the future.

Co-authorship network of co-authors of Gitte‐Bettina Nyvang

This figure shows the co-authorship network connecting the top 25 collaborators of Gitte‐Bettina Nyvang. A scholar is included among the top collaborators of Gitte‐Bettina Nyvang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gitte‐Bettina Nyvang. Gitte‐Bettina Nyvang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Mirza, Mansoor R., Line Bjørge, Frederik Marmé, et al.. (2024). Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial. Gynecologic Oncology. 192. 128–136. 3 indexed citations
3.
Steiniche, Torben, Boe Sandahl Sørensen, Gitte‐Bettina Nyvang, et al.. (2023). Circulating cell‐free HPV DNA is a strong marker for disease severity in cervical cancer. Molecular Oncology. 18(5). 1231–1244. 8 indexed citations
4.
5.
6.
Stougaard, Magnus, Boe Sandahl Sørensen, Estrid Høgdall, et al.. (2022). The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients. Cells. 11(14). 2170–2170. 25 indexed citations
7.
Harter, Philipp, Mariusz Bidziński, Nicoletta Colombo, et al.. (2019). DUO-O: A randomized phase III trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients.. Journal of Clinical Oncology. 37(15_suppl). TPS5598–TPS5598. 33 indexed citations
8.
Mirza, Mansoor Raza, Elisabeth Åvall‐Lundqvist, Michael J. Birrer, et al.. (2019). Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24.. Journal of Clinical Oncology. 37(15_suppl). 5505–5505. 7 indexed citations
9.
Knudsen, Anja Ør, Doris Schledermann, Gitte‐Bettina Nyvang, Ole Mogensen, & Jørn Herrstedt. (2016). Trends in gynecologic cancer among elderly women in Denmark, 1980–2012. Acta Oncologica. 55(sup1). 65–73. 19 indexed citations
10.
Tanderup, Kari, S.K. Nielsen, Gitte‐Bettina Nyvang, et al.. (2010). From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiotherapy and Oncology. 94(2). 173–180. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Kridelka Breakdown of academic impact, for papers by Jacob P. Hoogendam Breakdown of academic impact, for papers by Wharton Jt Breakdown of academic impact, for papers by Bastiaan G. Wortman Breakdown of academic impact, for papers by Emily MacDuffie Breakdown of academic impact, for papers by L Ševčík Breakdown of academic impact, for papers by M. Tiffany Breakdown of academic impact, for papers by R. Houghton Breakdown of academic impact, for papers by James L. Wilder Breakdown of academic impact, for papers by Caroline Lundgren
Rankless by CCL
2026